KEITH A. GOLDAN
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
ARMANDO ANIDO, MICHAEL COLA, MICHAEL F. COLA, JEANNE CUNICELLI, JAMES A. DATIN, MICHAEL C. DIEM, JOHN H. DILLON, II, BART J. DUNN, WILLIAM J. FEDERICI, EZRA H. FELKER, SUZANNE M. HANLON, JANE H. HOLLINGSWORTH, RICHARD S. KOLLENDER, GARY J. KURTZMAN, MICHAEL F. MARINO, GERALD W. MCLAUGHLIN, ROBERT P. ROCHE, TERRI B. SEBREE, BRIAN J. SISKO, WAYNE P. YETTER
EXECUTIVE OFFICER
SEAN D. BUCKLEY, DECLAN DALY, PAUL HOPPER, JULIAN KIRK, JULIAN P. KIRK, GEORGE KORKOS, GEORGE J. KORKOS, ROBERT LANGER, ROBERT LANGOR, MICHAEL F. MARINO, JOHN MASLOWSKI, JOHN M. MASLOWSKI, MARC MAZUR, MARC B. MAZUR, KELVIN MOORE, KELVIN D. MOORE, DAVID PERNOCK, MARCUS SMITH, MARCUS E. SMITH, CHRISTINE ST.CLARE, DOUGLAS J. SWIRSKY
EXECUTIVE OFFICER
HENRIK BRUUN ANDERSEN, ERIC BEDNARSKI, VICTOR CLAVELLI, VICTOR M. CLAVELLI, KLAAS DE BOER, KYLE DEMPSEY, HELENA KYTTARI DJUPESLAND, PER DJUPESLAND, WILLIAM F DOYLE, WILLIAM F. DOYLE, R. JOHN FLETCHER, TOM GIBBS, KEITH GOLDAN, WILHELMUS GROENHUYSEN, SANDRA L. HELTON, TOMAS J. HEYMAN, MICHELE JANIS, ANTHONY J. KRICK, RAMY MAHMOUD, RAMY A. MAHMOUD, MICHAEL MARINO, MICHAEL F. MARINO, PETER MILLER, PETER K. MILLER, ROBERT P. O-NEIL, PATRICK O-NEILL, CATHERINE E. OWEN, JACKSON PHILLIPS, LARRY PICKERING, JOSEPH C. SCODARI, PAUL SPENCE, JOSHUA TAMAROFF, JOSHUA A. TAMAROFF, TERRENCE TERIFAY, SRIRAM VENKATARAMAN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-11-16
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-08-18
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-09-12
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2016-08-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-10-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2011-08-02

